Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals

Journal of Experimental Medicine

Volumn 182, Issue 6, 1995, Pages 1857-1864

  Yellin, Michael J ^a   Brett, Jerald ^a   Baum, David ^a   Matsushima, Anne ^a   Szabolcs, Matthias ^a   Stern, David ^a   Chess, Leonard ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN;

ARTICLE; CELL INTERACTION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; CD40 LIGAND; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; IMMUNOLOGIC TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0028783397     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.6.1857     Document Type: Article

References (39)

1. Bevilacqua, M.P. 1993. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11: 767-804.
2. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76: 301-314.
3. Pober, J.S., and R.S. Cotran. 1991. Immunologic interactions of T lymphocytes with vascular endothelium. Adv. Immunol. 50: 261-302.
4. Potocnik, A.J., R. Kinne, H. Menninger, J. Zacher, F. Emmrich, and R.A. Kroczek. 1990. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand. J. Immunol. 31: 213-224.
5. Pauli, S., B. Ehlin-Henriksson, H. Mellstedt, H. Koho, H. Ben-Aissa, and P. Perlmann. 1985. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 20: 23-28.
6. Clark, E.A., andj. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA. 83: 4494-4498.
7. Alderson, M.R., R.J. Armitage, T.W. Tough, L. Strockbine, W.C. Fanslow, and M.K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669-674.
8. Freudenthal, P.S., and R.M. Steinman. 1990. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA. 87: 7698-7702.
9. Valent, P., O. Majdic, D. Maurer, M. Bodger, M. Muhm, and P. Bettelheim. 1990. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int. Arch. Allergy Appl. Immunol. 91: 198-203.
10. Young, L.S., C.W. Dawson, K.W. Brown, and A.B. Rickinson. 1989. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor ofB lymphocytes. Int.J. Cancer. 43: 786-794.
11. Galy, A.H., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149: 775-782.
12. Yellin, M.J., S. Winikoff S.M. Fortune, D. Baum, M.K. Crow, S. Lederman, and L. Chess. 1995. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) upregulation, IL-6 production and proliferation. J. Leukoc. Biol. 58: 209-216.
13. Lederman, S., M.J. Yellin, A. Krichevsky, J. Belko, J.J. Lee, and L. Chess. 1992. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).J. Exp. Med. 175: 1091-1101.
14. Lane, P., A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22: 2573-2578.
15. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K. N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, S.T. Davis, C.R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lond.). 357: 80-82.
16. Graf, D., U. Korthauer, H.W. Mages, G. Senger, and R.A. Kroczek. 1992. Cloning of TRAP, a ligand for CD40 on human T cells. Eur.J. Immunol. 22: 3191-3194.
17. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N.J. Chalupny, S. Braesch-Andersen, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO (Eur. Mol. Biol. Organ.) J. 11: 4313-4321.
18. Noelle, R.J., M. Roy, D.M. Shepherd, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89: 6550-6554.
19. Lederman, S., M.J. Yellin, A.M. Cleary, S.M. Fortune, and L. Chess. 1994. The understanding of contact-dependent T-cell helper function in molecular, cellular and physiological detail. Res. Immunol. 145: 215-220.
20. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12: 881-922.
21. Caux, C., C. Massacrier, B. Banbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180: 1263-1272.
22. Yellin, M.J., J. Sinning, L.R. Covey, W. Sherman, J.J. Lee, N.E. Glickman, K.C. Sippel, J. Rogers, A.M. Cleary, M. Parker, et al. 1994. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J. Immunol. 153: 666-674.
23. Lederman, S., M.J. Yellin, G. Inghirami, J.J. Lee, D.M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149: 3817-3826.
24. Favaloro, E.J. 1993. Differential expression of surface antigens on activated endothelium. Immunol. Cell Biol. 71: 571-581.
25. Holthofer, H., I. Virtanen, A.L. Kariniemi, M. Hormia, E. Linder, and A. Miettinen. 1982. Ulex europaeus I lectin as a marker for vascular endothelium in human tissue. Lab. Invest. 47: 60-66.
26. Fina, L., H.V. Molgaard, D. Robertson, N.J. Bradley, P. Monaghan, D. Delia, R.D. Sutherland, M.A. Baker, and M. F. Greaves. 1990. Expression of the CD34 gene in vascular endothelial cells. Blood. 75: 2417-2426.
27. Ranheim, E.A., and T.J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177: 925-935.
28. Hughes, C.C., C.O. Savage, andJ.S. Pober. 1990. The endothelial cell as a regulator of T-cell function. Immunol. Rev. 117: 85-102.
29. Kennedy, M.K., K.M. Mohler, K.D. Shanebeck, P.R. Baum, K.S. Picha, C.A. Otten-Evans, C.A. Janeway, and K.H. Grabstein. 1994. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24: 116-123.
30. Maliszewski, C.R., K. Grabstein, W.C. Fanslow, R. Armitage, M.K. Spriggs, and T.A. Sato. 1993. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 23: 1044-1049.
31. Karmann, K., C.C.W. Hughes, J. Schechner, W.C. Fanslow, andJ.S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA. 92: 4342-4346.
32. Hollenbaugh, D., N. Mischel-Petty, C.P. Edwards, J.C. Simons, R.W. Denfeld, P.A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182: 33-40.
33. Barrett, T.B., G. Shu, and E.A. Clark. 1991. CD40 signalling activates CDlla/CD18 (LFA-l)-mediated adhesion in B cells. J. Immunol. 146: 1722-1729.
34. Koch, A.E., J.C. Burrows, G.K. Haines, T.M. Carlos, J.M. Harlan, and S.J. Leibovich. 1991. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid arthritis and osteoarthritis synovial tissues. Lab. Invest. 64: 313-320.
35. Gruschwitz, M.S., O.P. Homstein, and P. von den Driesch. 1995. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum. 38: 184-189.
36. Wick, G., G. Schett, A. Amberger, R. Kleindienst, and Q. Xu. 1995. Is atherosclerosis an immunologically mediated disease? Immunol. Today. 16: 27-33.
37. Salomon, R.N., C.C.W. Huges, F.J. Schoen, D.D. Payne, J.S. Pober, and P. Libby. 1991. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am. J. Pathol. 138: 791-798.
38. Durie, F.H., R.A. Fava, T.M. Foy, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (Wash. DC). 261: 1328-1330.
39. Durie, F.H., T.M. Foy, and R.J. Noelle. 1994. The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease. Res. Immunol. 145: 200-205.